Key Sessions
Judy Chou
KEYNOTE PRESENTATION: Today’s Challenges and Opportunities in Biomanufacturing
Bayer Pharmaceuticals
Parrish Galliher
KEYNOTE PRESENTATION: BioPharma Tomorrow: Rethinking Efficiency
GE Healthcare Life Sciences
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
DAY ONE
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
DAY ONE
search
Streams
Formats
09:30 - 10:3060 mins
Registration and Opening of CPhI worldwide Exhibition Halls
10:30 - 13:50200 mins
Bioproduction Main Opening Plenary Session
The main Bioproduction conference will begin at 13:50 with the opening plenary talks. Attendees are welcome to attend the sessions taking place in the Bioproduction Theatre part of CPhI worldwide Exhibition prior to this start time.
10:30 - 11:4070 mins
Bioproduction Theatre part of CPhI worldwide Exhibition
Training Workshop: An Introduction to Biopharmaceutical Processing, Current Strategies and Future Landscape
- John Milne - Training Director, NIBRT
11:50 - 12:2030 mins
Bioproduction Theatre part of CPhI worldwide Exhibition
Reinventing the CMO Client Experience: Case Studies in Adapting to the Industry and Client Needs
- Richard Lee - Head of Drug Product Business Unit, Samsung BioLogics
- Brad Larson - Executive Director, DP Account Management, Samsung BioLogics
12:30 - 13:0030 mins
Bioproduction Theatre part of CPhI worldwide Exhibition
Adapting Manufacturing Strategies and Facilities to Next Generation Biotherapeutics and Emerging Therapies
- Dave Wolton - Operations Consultant, PM Group
13:10 - 13:4030 mins
Bioproduction Theatre part of CPhI worldwide Exhibition
Panel Discussion: Manufacturing and Commercialisation of Cell and Gene Therapies
- Ohad Karnieli - President and Co-Founder, Atvio Biotech
- Ian Dacey - Process Subject Mater Expert, PM Group
13:50 - 14:0010 mins
Bioproduction Main Opening Plenary Session
Chairperson's Opening Remarks
- Amir Goudarzi - Head Process Engineering Biologics Pilot Plant, UCB
14:00 - 14:3030 mins
Bioproduction Main Opening Plenary Session
KEYNOTE PRESENTATION: Today’s Challenges and Opportunities in Biomanufacturing
- Judy Chou - Senior Vice President & Global Head of Biotech; Site Head of Bayer Berkeley CA USA, Bayer Pharmaceuticals
14:30 - 15:0030 mins
Bioproduction Main Opening Plenary Session
KEYNOTE PRESENTATION: BioPharma Tomorrow: Rethinking Efficiency
- Parrish Galliher - CTO - Upstream, GE Healthcare Life Sciences
15:00 - 15:3030 mins
Afternoon Coffee Break & Networking
15:30 - 16:0030 mins
Cell Line Development
High Speed Cell Line Development for Short Timelines to IND
- David Kentner - Principal Scientist, Novartis
15:30 - 16:0030 mins
Upstream Processing & Cell Culture
Continuous USP using HCD Perfusion and Alternating Bioreactors
- Ard Tijsterman, MSc - Chief Executive Officer, Biosana Pharma BV
15:30 - 16:0030 mins
Downstream Processing
New Paradigm in ADC Polishing
- Romas Skudas - Senior Manager, Merck KGaA
15:30 - 16:0030 mins
Manufacturing Strategies & Bioprocessing 4.0
Learnings and Challenges in Industrialization of Late Stage Biopharmaceuticals
- Amir Goudarzi - Head Process Engineering Biologics Pilot Plant, UCB
15:30 - 16:0030 mins
Bioanalytical & Formulation
KEYNOTE: Deploying Appropriate Spending on Analytical Testing To Avoid Wasting Resources
- Gerald Gellermann - Senior Fellow, Novartis Biologics
16:00 - 16:3030 mins
Cell Line Development
Bispecific Molecule Formats and Concepts for Cell Line Development
- Holger Richly - Head of Laboratory Biologicals Development / Molecular Biology, Boehringer Ingelheim Pharma GmbH & Co. KG
16:00 - 16:3030 mins
Upstream Processing & Cell Culture
Comparison of Alternative Perfusion Systems for Intensified (N-1) Inoculum Generation
- Steven Ruddock - Senior Research and Development Manager, BioPharmaceutical Development, Astra Zeneca
16:00 - 16:3030 mins
Downstream Processing
Development and Implementation of a Harmonized Purification Platform for a Modern, Diverse Pipeline
- Florian Capito, Sanofi-Aventis Deutschland GmbH
16:00 - 16:3030 mins
Manufacturing Strategies & Bioprocessing 4.0
Driving Continuous Improvement with Large Scale Manufacturing
- Ken Green, Ph.D - Head of Cell Culture Manufacturing, Samsung Biologics
16:00 - 16:3030 mins
Bioanalytical & Formulation
A Case Study for Re-formulating a Commercial Monoclonal Antibody for New Therapeutic Applications
- Lorène Bernasconi - Head of Analytical and Bioanalytical Development, Sobi
16:30 - 17:0030 mins
Cell Line Development
Integrating Synthetic Biology Into Upstream Process Development
- Adam Brown - Lecturer in DNA Engineering, University of Sheffield, UK
16:30 - 17:0030 mins
Upstream Processing & Cell Culture
Media Development Combined With Frozen Process Intermediates For Intensified Seed Train Expansion
- Luis Fernando Ayala Solares - Scientist, Life Science, Upstream R&D, Merck KGaA
16:30 - 17:0030 mins
Downstream Processing
The Purification of Influenza A Virus Subtype H1N1 Using New Ion Exchanger
- Wei Zhang - Associate Staff Scientist, Downstream Processing Group, Bioprocessing Technology Institute of Singapore, A*STAR
16:30 - 17:0030 mins
Manufacturing Strategies & Bioprocessing 4.0
Monoclonal Antibody Disulfide Bond Reduction In Clinical Manufacturing and Mitigation using Copper Sulfate: A Case Study
- Sanjay Nilapwar, Ph.D. - Senior Research Investigator (Purification Development), Incyte Corporation
16:30 - 17:0030 mins
Bioanalytical & Formulation
Risk Assessments Based On Immunogenicity Assays
- Harry Yang - Senior Director, Medimmune, USA
17:00 - 17:3030 mins
Cell Line Development
Smart Strategies to Enhance Productivity, Improve Titers, Cell Culture Performance and Product Quality.
- Florian M. Wurm - Professor Emeritus, Swiss Federal Institute of Technology Lausanne (EPFL)
17:00 - 17:3030 mins
Upstream Processing & Cell Culture
Building Quality and Consistency into Bioproduction Media and Supplements
- Stacy Holdread - Manager, Research & Development, Thermo Fisher Scientific
17:00 - 17:3030 mins
Downstream Processing
Continuous Bioprocessing –The Alignment of Future Strategies to Industry 4.0
- Peter Levison, Ph.D. - Executive Director Business Development, Pall Life Sciences
17:00 - 17:3030 mins
Manufacturing Strategies & Bioprocessing 4.0
Design Considerations Towards an Intensified Single-Use Facility
- Gerben Zijlstra - Global Technology Consultant, Continuous & Intensified Biomanufacturing, Sartorius Stedim Biotech
17:00 - 17:3030 mins
Bioanalytical & Formulation
Introducing QbD in the Production of a Biologic Drug- Multiple Attribute Methodology and Host Cell Protein analysis
- Christian Baumann - Biologics Workflow Specialist, Sciex Germany
17:30 - 18:0030 mins
End of Day One
Get the latest news.
As it happens
Sign up to get the latest on the agenda and speakers.
Filter
Streams
Formats
Choose Day